| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Tom A Gardiner, Desmond B Archer, Tim M Curtis, Alan W Stit. Arteriolar involvement in the microvascular lesions of diabetic retinopathy: implications for pathogenesis. Microcirculation (New York, N.Y. : 1994). vol 14. issue 1. 2007-04-18. PMID:17365659. |
diabetic retinopathy (dr) is the most widespread complication of diabetes mellitus and a major cause of blindness in the working population of developed countries. |
2007-04-18 |
2023-08-12 |
human |
| Junichi Ideno, Hiroaki Mizukami, Akihiro Kakehashi, Yuka Saito, Takashi Okada, Masashi Urabe, Akihiro Kume, Masatoshi Kuroki, Masanobu Kawakami, Shun Ishibashi, Keiya Ozaw. Prevention of diabetic retinopathy by intraocular soluble flt-1 gene transfer in a spontaneously diabetic rat model. International journal of molecular medicine. vol 19. issue 1. 2007-03-19. PMID:17143550. |
the number of patients suffering from diabetes mellitus is constantly rising worldwide, and diabetic retinopathy (dr) has become the most frequent cause of postnatal blindness. |
2007-03-19 |
2023-08-12 |
human |
| Sarah X Zhang, Jian-xing M. Ocular neovascularization: Implication of endogenous angiogenic inhibitors and potential therapy. Progress in retinal and eye research. vol 26. issue 1. 2007-02-20. PMID:17074526. |
ocular neovascularization (nv) is the primary cause of blindness in a wide range of ocular diseases, such as diabetic retinopathy (dr) and age-related macular degeneration (amd). |
2007-02-20 |
2023-08-12 |
Not clear |
| Asif N Butt, Zaid Shalchi, Karim Hamaoui, Andjeny Samadhan, Jake Powrie, Shirley Smith, Sarah Janikoun, R Swaminatha. Circulating nucleic acids and diabetic complications. Annals of the New York Academy of Sciences. vol 1075. 2007-01-10. PMID:17108219. |
dr is the leading cause of blindness and diabetic nephropathy is the leading cause of end-stage renal failure. |
2007-01-10 |
2023-08-12 |
human |
| Ian N McRitchie, Patricia M Hart, R John Winde. Image registration and subtraction for the visualization of change in diabetic retinopathy screening. Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society. vol 30. issue 3. 2006-12-05. PMID:16631349. |
diabetic retinopathy (dr) is a leading cause of blindness in people of working age in developed countries. |
2006-12-05 |
2023-08-12 |
Not clear |
| Hideaki Hara, Kentaro Oh-hashi, Shinji Yoneda, Masamitsu Shimazawa, Masaru Inatani, Hidenobu Tanihara, Kazutoshi Kiuch. Elevated neprilysin activity in vitreous of patients with proliferative diabetic retinopathy. Molecular vision. vol 12. 2006-09-21. PMID:16943769. |
diabetic retinopathy (dr) is the leading cause of blindness in the industrialized world. |
2006-09-21 |
2023-08-12 |
Not clear |
| Gregg T Lueder, Janet Silverstei. Screening for retinopathy in the pediatric patient with type 1 diabetes mellitus. Pediatrics. vol 116. issue 1. 2005-12-13. PMID:15995070. |
diabetic retinopathy (dr) is the leading cause of blindness in young adults in the united states. |
2005-12-13 |
2023-08-12 |
Not clear |
| Francesco Chiarelli, Cosimo Giannini, Daniele Di Marzio, Angelika Moh. Treating diabetic retinopathy by tackling growth factor pathways. Current opinion in investigational drugs (London, England : 2000). vol 6. issue 4. 2005-12-05. PMID:15898347. |
diabetic retinopathy (dr) remains a major cause of new cases of blindness onset in adults. |
2005-12-05 |
2023-08-12 |
Not clear |
| E C Leal, A R Santiago, A F Ambrósi. Old and new drug targets in diabetic retinopathy: from biochemical changes to inflammation and neurodegeneration. Current drug targets. CNS and neurological disorders. vol 4. issue 4. 2005-11-15. PMID:16101558. |
diabetic retinopathy (dr) is a major complication of diabetes and is a leading cause of blindness in western countries. |
2005-11-15 |
2023-08-12 |
Not clear |
| Elvia Rodríguez-Villalobos, Fernando Cervantes-Aguayo, Enrique Vargas-Salado, María Elena Avalos-Muñoz, Dulce María Juárez-Becerril, Ector Jaime Ramírez-Barb. [Diabetic retinopathy: twelve-year incidence and progression]. Cirugia y cirujanos. vol 73. issue 2. 2005-10-17. PMID:15910698. |
diabetic retinopathy (dr) it is the main cause of preventable blindness in productive-age adults. |
2005-10-17 |
2023-08-12 |
Not clear |
| Elvia Rodríguez-Villalobos, Fernando Cervantes-Aguayo, Enrique Vargas-Salado, María Elena Avalos-Muñoz, Dulce María Juárez-Becerril, Ector Jaime Ramírez-Barb. [Diabetic retinopathy: twelve-year incidence and progression]. Cirugia y cirujanos. vol 73. issue 2. 2005-10-17. PMID:15910698. |
the rate of progression to blindness from dr differs among countries and populations. |
2005-10-17 |
2023-08-12 |
Not clear |
| S Subedi, K U Subedi, B P Badh. Doctor's role in early detection of diabetic retinopathy and prevention of blindness from its complications. JNMA; journal of the Nepal Medical Association. vol 44. issue 157. 2005-10-13. PMID:16152680. |
diabetic retinopathy (dr) is a microangiopathy, which is caused by chronic hyperglycemia, affecting the retinal arterioles, capillaries and venules, complications of which lead to incurable blindness. |
2005-10-13 |
2023-08-12 |
Not clear |
| K G Santos, B Tschiedel, J R Schneider, K E P Souto, I Roisenber. Prevalence of retinopathy in Caucasian type 2 diabetic patients from the South of Brazil and relationship with clinical and metabolic factors. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. vol 38. issue 2. 2005-10-03. PMID:15785833. |
diabetic retinopathy (dr) is a sight-threatening chronic complication of diabetes mellitus and is the leading cause of acquired blindness in adults. |
2005-10-03 |
2023-08-12 |
Not clear |
| Cristiano Giust. Are phospholipid-binding antibodies implicated in the pathogenesis of diabetic microangiopathy? Medical hypotheses. vol 63. issue 2. 2005-02-24. PMID:15236781. |
diabetic retinopathy (dr) is a major cause of blindness in the working population of the western world and there is no doubt that its prevalence is strongly related to the duration of diabetes and the glycemic control. |
2005-02-24 |
2023-08-12 |
human |
| Karin S Coyne, Mary Kay Margolis, Tessa Kennedy-Martin, Timothy M Baker, Ronald Klein, Matthew D Paul, Dennis A Revick. The impact of diabetic retinopathy: perspectives from patient focus groups. Family practice. vol 21. issue 4. 2004-12-21. PMID:15249536. |
diabetic retinopathy (dr) affects 50-85% of people with diabetes and may result in visual impairment or blindness. |
2004-12-21 |
2023-08-12 |
Not clear |
| C Giust. Retinopathy in juvenile diabetes: a 10-year (1990-2000) review. Pediatric diabetes. vol 2. issue 2. 2004-06-30. PMID:15016202. |
there is general agreement that early diagnosis and treatment of dr can slow its progression and help to prevent blindness. |
2004-06-30 |
2023-08-12 |
Not clear |
| Dominique Chauvau. [Non-insulin-dependent diabetes: an expanding disease. Diabetic ophthalmopathy: diabetic retinopathy facts]. Bulletin de l'Academie nationale de medecine. vol 187. issue 7. 2004-06-01. PMID:15146607. |
diabetic retinopathy (dr) is the 5th cause of blindness in the population of less than 50 years old in industrialized countries. |
2004-06-01 |
2023-08-12 |
Not clear |
| G Grass. Diabetic retinopathy. Minerva medica. vol 94. issue 6. 2004-05-13. PMID:14976470. |
diabetic retinopathy (dr) in the way of proliferative retinopathy (pdr) and macular oedema (me) is the commonest cause of new cases of legal blindness in europe as in north america in the age group 30 to 70-74 years. |
2004-05-13 |
2023-08-12 |
Not clear |
| Thomas A Ciulla, Armando G Amador, Bernard Zinma. Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies. Diabetes care. vol 26. issue 9. 2004-04-23. PMID:12941734. |
diabetic retinopathy (dr) and diabetic macular edema (dme) are leading causes of blindness in the working-age population of most developed countries. |
2004-04-23 |
2023-08-12 |
Not clear |
| W-J Liu, L-T Lee, M-F Yen, T-H Tung, R Williams, S W Duffy, T H-H Che. Assessing progression and efficacy of treatment for diabetic retinopathy following the proliferative pathway to blindness: implication for diabetic retinopathy screening in Taiwan. Diabetic medicine : a journal of the British Diabetic Association. vol 20. issue 9. 2003-12-09. PMID:12925052. |
therefore, the natural history of dr and rates of transition after treatment (including metabolic control and laser photocoagulation) from no diabetic retinopathy (ndr) to blindness were quantified. |
2003-12-09 |
2023-08-12 |
Not clear |